Sera from patients with cystic fibrosis of the pancreas (CF) and normal human sera were assayed for the ability to inhibit sodiumdependent glucose transport in rat brush-border membrane vesicles. Fresh CF and age-and sex-matched control sera were both inhibitory when compared to physiologic saline. The inhibition by CF serum was 44 f 13% (mean 2 SD) at a final serum concentration of 6.7%, 67 f 34% at 10% serum, and 68 2 28% at 20% serum.
Summary
Sera from patients with cystic fibrosis of the pancreas (CF) and normal human sera were assayed for the ability to inhibit sodiumdependent glucose transport in rat brush-border membrane vesicles. Fresh CF and age-and sex-matched control sera were both inhibitory when compared to physiologic saline. The inhibition by CF serum was 44 f 13% (mean 2 SD) at a final serum concentration of 6.7%, 67 f 34% at 10% serum, and 68 2 28% at 20% serum.
The ratio of the inhibition of CF sera compared to that of control sera was 1.00,0.78, and 0.93 at 6.7, 10, and 20% serum concentrations, respectively. Although a slightly greater inhibition by CF serum was observed at a concentration of lo%, this is probably not significant because no difference could be detected at a concentration of 20% serum. Glucose transport in the presence of serum was sensitive to phlorizin indicating that the residual glucose transport was proceeding by the sodiumdependent glucose transport system. These findings suggest that CF serum does not specifically inhibit the sodium-dependent glucose transport system.
The intravesicular space accessible to glucose was reduced in the presence of CF or control serum. Fresh CF serum was 1.4 times more effective than fresh control serum (P < 0.01). The presence of substantial vesicle-shrinking activity in control serum indicates that this activity cannot be considered specific for CF.
Speculation
The CF specific factor that inhibits sodium transport may be effective only with epithelial tissues capable of transporting sodium chloride against high concentration gradients, such as the epithelia of the ducts of the saliva and sweat glands, the colon, the distal renal tubules, and the renal collecting tubules.
Considerable evidence has been reported that a factor (or factors) in the sweat or saliva from patients with C F inhibits sodium reabsorption by specific epithelia (I 1, 21, 23-25, 33, 37) . This factor has not been isolated, principally because of its lability and the lack of a convenient and reliable assay system. The retrograde perfusion assay of the rat parotid, for example, is quite difficult (5, 37, 42) . Recently a new assay was suggested that involved measuring the inhibition of the intestinal glucose-dependent sodium transport by C F serum (1). The sodium transport was measured electrically as the short-circuit current, and the assay was potentially accurate and rapid. Unfortunately, additional observations noted that the inhibitory activity was not unique to CF sera, but was also present in control sera (2).
In other studies employing intestinal rings, it was found that the 60-min uptake of glucose analogs was inhibited more by C F sera than by normal sera (3, 7). As these experiments were not performed to study transport rates strictly, the results do not necessarily indicate an effect of CF-serum on membrane transport of glucose. The 60-min uptake of the glucose analogs represents the steady state levels of accumulation. These steady state levels can be affected by many different factors, particularly those that interfere with metabolism, energetics, cell viability, and plasma membrane integrity.
Nevertheless, the previously mentioned studies suggested that CF sera might inhibit sodium-dependent glucose transport in the small intestine. In order to directly assess this effect, the ability of CF and control sera to inhibit sodium-dependent glucose transport in rat jejunal brush-border membrane vesicles was examined. This is a well established system for measuring nonelectrolyte and electrolyte transport, and has been invaluable for characterizing sodium and sodium-dependent transport systems of the intestinal brush-border membrane (17, 20, 28, 34) . Due to the stoichiometric coupling between sodium and glucose during transport (28, 32) . inhibition of the glucose transport system might be expected to affect equally the sodium and glucose fluxes. Whereas sodium is taken up by glucose-independent and glucose-dependent pathways, glucose transport by brush-border membrane vesicles occurs predominantly via cotransport with sodium. Therefore, the uptake of glucose was chosen to evaluate the effects of sera on the sodiumdependent glucose transport system.
MATERIALS A N D METHODS PATIENTS A N D CONTROL SUBJECTS
Patients contributing serum for this study were from the Cleveland Cystic Fibrosis Center. At the time serum was collected, none had received antibiotics or pharmacologic agents other than pancreatic enzymes and vitamins for at least 24 hr. Their clinical scores ranged from 46-84 (12) . Control donors were either patients hospitalized for nonpulmonary, noninflammatory conditions, student volunteers, or young laboratory personnel. CF patients and normal donors were matched for sex and for age as much as possible. Informed consent was obtained from patients and volunteers contributing serum.
SERUM COLLECTlON AND TREATMENT
Venous blood was collected into plastic tubes without anticoagulants. The blood was clotted at 37' (typically 3-20 min) and the clot was separated by centrifuging at 2100 x g for 15 min at 4". The serum was collected and stored at 04' in polyethylene tubes. Plastic equipment was used for all manipulations. Unless otherwise indicated, the serum samples were assayed for transportinhibiting activity within 56 hr of collection (four within 8 hr of collection). Hemolyzed samples were discarded. Serum protein and glucose concentrations were measured using established methods (22, 41). (20); the purification observed in nine experiments was 18 + 5-fold. Membrane protein was measured by the method of Bensadoun and Weinstein (6). Membrane vesicles, suspended in 0.1 M D-mannitol and 1 mM Tris-Hepes pH 7.5, were preincubated with 0.11 M sodium chloride, 20 pg/ml monactin and either physiologic saline (control) or dilutions of serum for 15 min at 25'. The ionophore monactin was added to prevent changes of the membrane potential during glucose transport (17, 28). Unless otherwise indicated, serum treatments were examined in duplicate or triplicate at final concentrations of 6.7, 10, and 20% (v/v) in physiologic saline. Dglucose uptake was initiated by addition of the labeled substrate (10 mM at a specific activity of 3 Ci/mole) and measured at frequent intervals using the membrane filtration assay (28). Virtually all of the glucose uptake is accounted for by transport into the intravesicular space (43). Rates were obtained at 25" as the reciprocal of the time required for half maximal uptake into the intravesicular space. This method has been shown to give reliable estimates of the D-glucose transport rate in isolated brush-border membrane vesicles (18). Uptake of D -~~u c o S~ by the sodiumdependent transport system was evaluated by including 100 pM phlorizin, which is a specific inhibitor of this system (17, 20) . The D-glucose concentration was I mM in these experiments.
Transport rates of the membrane vesicles vary somewhat between membrane preparations due to animal differences or other uncontrollable factors. Consequently, the data from serum-treated vesicles are expressed as the fractions of the equilibration rates of the saline-treated vesicles. Glucose transport into paired control and C F serum-treated vesicles was measured on the same membrane preparation at the same time. Intravesicular space was determined from the equilibrium uptake of D -~~u c o S~ after 20-40 min (average 25 min).
Sample variability is given as the mean + S D (n). Differences between groups were evaluated by the paired Student's r test where P < 0.05 was considered significant (40). 
RESULTS
The presence of serum decreased the initial and final D-gl~coSe uptake by vesicles of isolated brush border membranes (Fig. 1) . The lower equilibrium uptake indicates a loss of intravesicular space accessible to glucose. If the reduced space is due to vesicle shrinkage and the ratio of surface area to intravesicular space is increased, the apparent transport rate that is estimated as the reciprocal of the half-time (T%) in glucose equilibration must be corrected for the change in space. In this case (Model I), the transport rates measured in the presence of serum have to be normalized to the same surface area to space ratio as those measured in saline. Therefore, the transport rates were corrected by multiplying the observed with the value of the reduced ,pace expressed as fraction of the same vesicles in saline (for details, see Ref. 44) . Calculations based on Model I give a lower limit for the relative transport rates (for upper limits, see Ref. 44) .
The effects of C F and control sera on the glucose transport rates, calculated according to Model I, are shown in Figure 2 and summarized in Table I . The data indicate that serum significantly inhibited glucose transport at each of the concentrations examined. glucose. Uptake of glucose was measured as described in the Methods, and normalized to the uptake of the saline control (crosses) at equilibrium (14.1 + 0.8 nmole/mg membrane protein ( n = 4)). The equilibrium values were measured in triplicate and are plotted as the mean * SD. Both the control donor and the CF patient were 13-yr-old males.
At 6.7 and 20% serum, there was no significant difference between C F and control serum, whereas at lo%, C F serum was slightly more inhibitory than control serum. The inhibition of glucose transport by 10% C F serum did not correlate with the clinical scores of the patients. Therefore, the observed inhibition is not related to the severity of the disease.
Although the difference in inhibitory potency between C F and control serum at 10% is statistically significant ( P < 0.025) the factor(s) causing the inhibition cannot be considered CF-specific as a difference was observed only at the intermediate concentration. Even this difference may be artifactual due to the space correction employed. The uncorrected transport rates were essentially identical in the presence of C F and control serum (44). Attempts to correlate the inhibition by C F and control serum with either age or sex only revealed the absence of such correlations (see Fig. 2 ). Furthermore, the inhibition did not correlate with the time between the collection of the serum and the transport measurements, or the protein and glucose concentrations in the serum (45).
Serum apparently did not affect the transport mechanism for glucose as judged by sensitivity of the glucose transport to the specific inhibitor phlorizin. For example, in the presence of 6.7% C F serum, the rate of glucose uptake was decreased 60% by 0.1 mM phlorizin.
The reasons for the loss of intravesicular space in the presence of serum (Fig. I) are not clear. Replacement of human serum with either dialyzed human or bovine serum albumin resulted in only a slight decrease of vesicle volume so that the colloid-osmotic pressure of serum can be eliminated as a major cause. T o explore whether this effect is C F specific, the data on the equilibrium uptake of glucose was analyzed in more detail. The concentration of serum reauired for a 50% reduction of the glucose accessible space of salihe-treated vesicles was determinedvfrom plots of the equilibrium values versus serum concentration (not shown). The results (Table 2) indicate that fresh C F serum was significantly more effective than fresh control serum in reducing the space accessible to glucose. However, the activity in serum was increased by freezing and a comparison of frozen C F sera with frozen control sera indicated a similar concentration of this activity in both groups (Table 2) . It is thus unlikely that the serum activity that reduced the equilibrium space can be attributed to a C F factor because it was present in normal serum. The manifestation of the vesicle shrinking activity in fresh C F serum may be due to other factors in serum which are destroyed by freezing. The substance(s) in normal and C F serum that reduced the equilibration space was dialysable (22 hr against 100 volumes of saline at SODIUM-DEPENDENT GLUCOSE TRANSPORT 1131 20 %(v/v) serum Table I . Effect of serum on the relative u take rate of glucose by Fig. 2 . The effect of CF, sex, and age on serum inhibition of the glucose uptake rate by membrane vesicles. @, V = C F serum; 0, V = normal control serum; @, 0 = females; V, V = males. Glucose uptake was normalized to the uptake rate observed in saline-treated vesicles measured with the same membrane preparation as described in the text. The time for 50% glucose equilibration of saline-treated vesicles was 21 * 6 sec ( n = 7) for the different preparations used in this study. The coefficient of variance observed with the individual serum concentrations was generally 15%.
2"). stable to heat (56" for 30 min), and tolerated freezing and treatment with powdered glass (25% by weight at 2" for 18 hr). These properties are different from those of previously described CF factors (I, 24, 25, 42) and contrast with activity inhibiting the rate of glucose transport which although dialyzable is heat labile (conditions the same as those previously discussed).
DISCUSSION
Transport inhibitory activities have been reported in CF saliva or sweat and in CF serum. The former activity inhibits sodium reabsorption in the ducts of the saliva and sweat glands, and although well accepted as a characteristic of CF, this activity has not been purified or identified because of the lability and difficulty of its assay (23, 24, 37, 42) .
Another CF-specific serum activity, the ciliary dyskinesia factor, has been partially purified (4, 8, 38, 39) , however, there is no known connection between this activity and the CF transport inhibitory activities in CF saliva, sweat, or serum. Indeed, the binding of the ciliary dyskinetic activity to C4 (8, 39) suggests that
Serum
Relative glucose uptake rate concentration Number % (v/v) Control serum CF serum of pairs Significance I The rates were determined as reciprocals of the times for 50% equilibration from plots as in Figure I . They were normalized to the same ratio of vesicle surface area to volume as that of saline-treated vesicles (see Resultsl. Saline-treated vesicles have a relative rate of I. it may be more related to secondary immunologic complications of CF than to the transport inhibitory activity that is a primary characteristic of CF (1 1, 24). CF serum has been reported to inhibit sodium or sodiumdependent nonelectrolyte transport in the rat small intestine more than control serum (1-3, 7, 16). The transport inhibitory activities present in CF saliva and CF serum are similar in that they inhibit sodium or sodium-dependent nonelectrolyte transport systems of epithelial tissues. However, there is no evidence that the same agent is responsible for the inhibitory effects of the two fluids. Actually, very different types of transport systems are probably involved in sodium reabsorption by the ducts of saliva and sweat glands, cotransport of glucose and sodium by the small intestine, and nonelectrolyte-independent sodium absorption by the small intestine. Hence, it is possible that different types of agents are responsible for inhibition of sodium transport via the different routes and that an assumed or implied identity of the factors is not warranted. Furthermore, the inhibition of sodium reabsorption by CF saliva or CF sweat is a well established phenomenon which clearly relates to the pathophysiology of abnormal sodium concentrations in the sweat and saliva from patients with CF (I I, 23-25). However, it is not obvious that the inhibition of glucosedependent short-circuit current (16) or the inhibition of the steady state uptake of nonelectrolytes in the intestine are related to the disease. The objective of this study was to extend the work of Araki et al. (1, 2) and attempt to detect a clearly defined membrane level interaction of CF serum with the sodium-dependent glucose transport system in the small intestine.
The results of this study generally confirm previous observations that indicated that the transport inhibitory activity in human serum is not specific for either the transported solute or CF (5, 9, 10, 27, 35, 36) , but are at variance with the reports that stimulated this investigation (1, 3, 7, 16) . These discrepancies in experimental findings may be a result of either the experimental methods (see Materials and Methods) or the specific patients and controls included in the various studies. padent and control selection is a crucial point in investigations of this type as CF patients may differ from controls for reasons not related to the primary defect in CF. For example, variations may be caused by specific and calculated transport rates based on Model I glve the lower limits of the true rates. If the ratio of the intravesicular space to the surface area remains constant, then the T,,r should be independent of the intravesicular space (Model 11). The reciprocal of the T,,? would be an estimate of the relative transport rates and could be used to compare the effects of CF and control serum on glucose transport (17). Model 11 gives an upper limit for the relative glucose transport rate. Using Model 11. there was no significant difference between the rates in the presence of control or C F serum: 
